
MOTION FOR A RESOLUTION on Commission Implementing Regulation (EU) 2019/707 of 7 May 2019 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances alpha-cypermethrin, beflubutamid, benalaxyl, benthiavalicarb, bifenazate, boscalid, bromoxynil, captan, cyazofamid, desmedipham, dimethoate, dimethomorph, diuron, ethephon, etoxazole, famoxadone, fenamiphos, flumioxazine, fluoxastrobin, folpet, foramsulfuron, formetanate, metalaxyl-m, methiocarb, metribuzin, milbemectin, Paecilomyces lilacinus strain 251, phenmedipham, phosmet, pirimiphos-methyl, propamocarb, prothioconazole, s-metolachlor and tebuconazole
Adopted
Reference: B9-0103/2019
Date: 10.10.2019
GUE/NGLThe Left in the European Parliament (GUE/NGL)
13 Members
Group Voting Result
- 13For
- 0Against
- 0Abstention
- 0Did not vote
Majority of the group: For · no deviations
Majority = position with the most votes in the group; "Did not vote" does not count. In case of a tie there is no majority and no deviators.











